Company / Book Value per Share
NewAmsterdam Pharma Co N.V. Book Value per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$18.849
FY2025
5-year range
-$10.367 / $22.675
FY2021-FY2025
Trend
-9.8%
vs FY2024
Sector context
#31 of 209
Health Care
What the data says
NewAmsterdam Pharma Co N.V.'s book value per share of $18.849 is higher than 85% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 5 years, ranging from -$10.367 in FY2021 to $22.675 in FY2022.
Based on SEC 10-K filings.
$18.849 in FY2025 with a 3-year CAGR of -6.0%. Top quartile in the Health Care sector.
Improved from $7.954 to $18.849 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -6.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-90.0% below sector average
Key checks
Key Insights
- 3-year CAGR of -6.0%, indicating a declining trend.
- In FY2025, book value per share decreased 9.8% year-over-year.
- Ranks #31 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.849 | -9.8% |
| FY2024 | $20.892 | +162.7% |
| FY2023 | $7.954 | -64.9% |
| FY2022 | $22.675 | +318.7% |
| FY2021 | -$10.367 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026